| Net Cash Provided by (Used in) Operating Activities |
-48.2K |
USD |
-1535% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
46.7K |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
10B |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
5.36B |
shares |
+19% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
79.8K |
USD |
+522% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
1.16M |
USD |
+13.3% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
1.16M |
USD |
+13.3% |
Q4 2024 |
FY 2024 |
| Depreciation |
322 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
5.5M |
USD |
+13.3% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
51 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
23.4K |
USD |
-96.8% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
51 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Interest Expense |
528K |
USD |
+42.5% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |